| __timestamp | Amphastar Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 31354781 |
| Thursday, January 1, 2015 | 37065000 | 43445817 |
| Friday, January 1, 2016 | 41199000 | 66489820 |
| Sunday, January 1, 2017 | 43415000 | 96886134 |
| Monday, January 1, 2018 | 57564000 | 153793000 |
| Tuesday, January 1, 2019 | 68853000 | 148369000 |
| Wednesday, January 1, 2020 | 67229000 | 151934000 |
| Friday, January 1, 2021 | 60932000 | 198532000 |
| Saturday, January 1, 2022 | 74771000 | 112128000 |
| Sunday, January 1, 2023 | 73741000 | 76192000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, TG Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, TG Therapeutics consistently outpaced Amphastar, with R&D expenses peaking in 2021 at nearly 200% of Amphastar's spending. This trend underscores TG Therapeutics' aggressive pursuit of novel therapies, particularly in the field of oncology. Meanwhile, Amphastar's steady increase in R&D, culminating in a 160% rise from 2014 to 2023, highlights its commitment to enhancing its portfolio of generic and specialty pharmaceuticals. As these companies continue to navigate the complexities of drug development, their R&D strategies will be pivotal in shaping their competitive edge and delivering groundbreaking treatments to patients worldwide.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
Pfizer Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.